Simplifying Global Compliance
GAO: Progress in FDA’s Overseas Inspections Still Hurt by Vacancies
International Pharmaceutical Regulatory Monitor
The FDA has made great strides in conducting international inspections — but still remains detrimentally understaffed, according to the government’s official watchdog, during a time when the agency has begun to inspect more sites overseas than within the U.S.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing